Hamad, S., Montgomery, S. A., Simon, J. M., Bowman, B. M., Spainhower, K. B., Murphy, R. M., … Weissman, B. E. (2022). The Nrf2^E79Q activating mutation accelerates growth of pure-small cell lung cancer but not combined small cell lung cancer Tp53^{floxed/floxed}/Cdkn2a^{floxed/floxed} mice. In CANCER RESEARCH (Vol. 82).

Hamad, Samera, Stephanie A. Montgomery, Jeremy M. Simon, Brittany M. Bowman, Kyle B. Spainhower, Ryan M. Murphy, Agnieszka Witkiewicz, et al. “The Nrf2^E79Q activating mutation accelerates growth of pure-small cell lung cancer but not combined small cell lung cancer Tp53^{floxed/floxed}/Cdkn2a^{floxed/floxed} mice.” In CANCER RESEARCH, Vol. 82, 2022.

Hamad S, Montgomery SA, Simon JM, Bowman BM, Spainhower KB, Murphy RM, et al. The Nrf2^E79Q activating mutation accelerates growth of pure-small cell lung cancer but not combined small cell lung cancer Tp53^{floxed/floxed}/Cdkn2a^{floxed/floxed} mice. In: CANCER RESEARCH. 2022.

Hamad, Samera, et al. “The Nrf2^E79Q activating mutation accelerates growth of pure-small cell lung cancer but not combined small cell lung cancer Tp53^{floxed/floxed}/Cdkn2a^{floxed/floxed} mice.” CANCER RESEARCH, vol. 82, no. 12, 2022.

Hamad S, Montgomery SA, Simon JM, Bowman BM, Spainhower KB, Murphy RM, Witkiewicz A, Fenton SE, Randell SH, Hayes N, Knudsen E, Oliver TG, Major B, Weissman BE. The Nrf2^E79Q activating mutation accelerates growth of pure-small cell lung cancer but not combined small cell lung cancer Tp53^{floxed/floxed}/Cdkn2a^{floxed/floxed} mice. CANCER RESEARCH. 2022.